Literature DB >> 20456254

Delayed epithelial healing following photorefractive keratectomy with mitomycin C treatment.

Israel Kremer1, Miriam Ehrenberg, Shmuel Levinger.   

Abstract

PURPOSE: To evaluate the epithelial healing following photorefractive keratectomy (PRK) with mitomycin C (MMC) 0.02%.
METHODS: A total of 1520 eyes of 760 patients with myopia with spherical equivalent between -1.5 and -8.0 dioptres underwent PRK during 2004-2008. The epithelium was removed mechanically, and laser ablation was followed by topical application of MMC (0.02%) for 20 seconds. A therapeutic contact lens (TCL), kept in 4°C, was fitted and worn until complete epithelialization. Antibiotic, steroid and diclofenac drops were instilled during the healing phase. Steroid drops were used for 6-8 weeks and gradually reduced. The results were compared with a retrospective analysis of 500 myopic eyes which underwent PRK without MMC therapy during 2002-2004.
RESULTS: In 30 MMC treated eyes (2%), epithelial healing was delayed with a stellate defect which healed after 12-14 days. Another fifteen eyes (1%) revealed loose midperipheral epithelium and complete epithelialization took 10-14 days after scraping. Two of these eyes developed recurrent erosion treated by scraping and TCL. Seven eyes (0.5%) revealed delayed healing with paracentral epithelial plaques which were scraped and complete healing took 12-14 days. No final haze was found in the MMC-treated eyes. In comparison, only 0.8% of the eyes which had undergone PRK without MMC revealed epithelial problems. Haze was found in 8% of these eyes. A statistically significant difference was found between the rate of epithelial problems of the two groups (p ≤ 0.002).
CONCLUSIONS: MMC (0.02%) applied for 20 seconds post-PRK was found to delay epithelial wound healing up to 14 days in 3.5% of patients with myopia compared to 0.8% of PRK eyes without MMC application. Final haze was not found despite delayed epithelialization because of MMC treatment.
© 2010 The Authors. Journal compilation © 2010 Acta Ophthalmol.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20456254     DOI: 10.1111/j.1755-3768.2010.01894.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  8 in total

Review 1.  Corneal Regeneration After Photorefractive Keratectomy: A Review.

Authors:  Javier Tomás-Juan; Ane Murueta-Goyena Larrañaga; Ludger Hanneken
Journal:  J Optom       Date:  2014-10-23

2.  Topical Mitomycin-C enhances subbasal nerve regeneration and reduces erosion frequency in the debridement wounded mouse cornea.

Authors:  Sonali Pal-Ghosh; Ahdeah Pajoohesh-Ganji; Gauri Tadvalkar; Briana M Kyne; Xiaoqing Guo; James D Zieske; Mary Ann Stepp
Journal:  Exp Eye Res       Date:  2015-08-30       Impact factor: 3.467

3.  Early outcomes after small incision lenticule extraction and photorefractive keratectomy for correction of high myopia.

Authors:  Tommy C Y Chan; Marco C Y Yu; Alex Ng; Zheng Wang; George P M Cheng; Vishal Jhanji
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

4.  Management of progressive keratoconus with partial topography-guided PRK combined with refractive, customized CXL - a novel technique: the enhanced Athens protocol.

Authors:  Anastasios John Kanellopoulos
Journal:  Clin Ophthalmol       Date:  2019-04-02

Review 5.  A Critical Overview of the Biological Effects of Mitomycin C Application on the Cornea Following Refractive Surgery.

Authors:  Esther Arranz-Marquez; Andreas Katsanos; Vassilios P Kozobolis; Anastasios G P Konstas; Miguel A Teus
Journal:  Adv Ther       Date:  2019-03-11       Impact factor: 3.845

6.  Delayed Epithelial Healing with Corneal Edema and Haze After Photorefractive Keratectomy Using Intraoperative Mitomycin C.

Authors:  Majid Moshirfar; William B West; Dallin C Milner; Shannon E McCabe; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Int Med Case Rep J       Date:  2021-12-24

Review 7.  Mitomycin C application after photorefractive keratectomy in high, moderate, or low myopia: Systematic review and meta-analysis.

Authors:  Yassamine Ouerdane; Mohamed Sayed Zaazouee; Moaiad Eldin Ahmed Mohamed; Mohammed Tarek Hasan; Mohamed Hamdy; Abdallah Magdy Ghoneim; Mohamed Ibrahim Gbreel; Ahmed Mohamed Ibrahim; Khaled Mohamed Ragab; Anas Zakarya Nourelden
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

8.  Safety and efficacy of combination of suberoylamilide hydroxyamic acid and mitomycin C in reducing pro-fibrotic changes in human corneal epithelial cells.

Authors:  Rohit Shetty; Nimisha Rajiv Kumar; Murali Subramani; Lekshmi Krishna; Ponnalagu Murugeswari; Himanshu Matalia; Pooja Khamar; Zelda V Dadachanji; Rajiv R Mohan; Arkasubhra Ghosh; Debashish Das
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.